Literature DB >> 16985755

Tumor markers: an update on human kallikrein 2.

S R Potter, A W Partin.   

Abstract

Entities:  

Year:  2000        PMID： 16985755      PMCID： PMC1476115     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  3 in total

1.  In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.

Authors:  M K Kwiatkowski; F Recker; T Piironen; K Pettersson; T Otto; M Wernli; R Tscholl
Journal:  Urology       Date:  1998-09       Impact factor: 2.649

2.  Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.

Authors:  A W Partin; W J Catalona; J A Finlay; C Darte; D J Tindall; C Y Young; G G Klee; D W Chan; H G Rittenhouse; R L Wolfert; D L Woodrum
Journal:  Urology       Date:  1999-11       Impact factor: 2.649

Review 3.  Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.

Authors:  H G Rittenhouse; J A Finlay; S D Mikolajczyk; A W Partin
Journal:  Crit Rev Clin Lab Sci       Date:  1998-08       Impact factor: 6.250
  3 in total
  1 in total

Review 1.  Current status of biomarkers for prostate cancer.

Authors:  Vicki M Velonas; Henry H Woo; Cristobal G dos Remedios; Stephen J Assinder
Journal:  Int J Mol Sci       Date:  2013-05-24       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.